Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 15/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 15/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 12/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.40 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | PLK4 | O00444 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.38 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.38 |
| ▸ | CSNK1G3 | Q9Y6M4 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4769722 | 0.89 | ADORA2B (0.48) | ADORA2BADORA2AADORA1ADORA3GRM4 | |
| SCHEMBL4763685 | 0.85 | ADORA2A (0.50) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL4771233 | 0.85 | ADORA2B (0.52) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL4770636 | 0.83 | ADORA2A (0.46) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL4763167 | 0.82 | ADORA2B (0.55) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL4771316 | 0.82 | ADORA2B (0.51) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL4769146 | 0.82 | ADORA2B (0.48) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL4771327 | 0.82 | ADORA2B (0.43) | ADORA2BADORA2AADORA1ADORA3GRM4 | |
| SCHEMBL4767749 | 0.81 | ADORA2A (0.44) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL4769743 | 0.80 | ADORA2B (0.58) | ADORA2BADORA2AADORA1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678181-B1 | A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS INC (US) | 2008-12-31 | — | — | EP | disclosed |